Literature DB >> 16507649

Absorption and metabolism of Astragali radix decoction: in silico, in vitro, and a case study in vivo.

Feng Xu1, Yue Zhang, Shengyuan Xiao, Xiaowei Lu, Donghui Yang, Xiaoda Yang, Changling Li, Mingying Shang, Pengfei Tu, Shaoqing Cai.   

Abstract

To profile absorption of Astragali Radix decoction and identify its orally absorbable constituents and their metabolites, four complementary in silico, in vitro, and in vivo methods, i.e., a computational chemistry prediction method, a Caco-2 cell monolayer model experiment, an improved rat everted gut sac experiment, and a healthy human volunteer experiment, were used. According to the in silico computation result, 26 compounds of Astragali Radix could be regarded as orally available compounds, including 12 flavonoids. In the in vitro and in vivo experiments, 21 compounds were tentatively identified by high-performance liquid chromatography-diode array detection-electrospray ion trap tandem mass spectrometry data, which involved calycosin, formononetin, (6aR,11aR)-3-hydroxy-9,10-dimethoxypterocarpan, 7,2'-dihydroxy-3',4'-dimethoxyisoflavan, calycosin-7-O-beta-D-glucoside, formononetin-7-O-beta-D-glucoside, 7,2'-dihydroxy-3',4'-dimethoxyisoflavan-7-O-beta-D-glucoside-6''-O-malonate, (6aR,11aR)-3-hydroxy-9,10-dimethoxypterocarpan-3-O-beta-D-glucoside, and phase II metabolites calycosin-7-O-beta-D-glucuronide, formononetin-7-O-beta-D-glucuronide, (6aR,11aR)-3-hydroxy-9,10-dimethoxypterocarpan-3-O-beta-D-glucuronide, 7,2'-dihydroxy-3',4'-dimethoxyisoflavan-7-O-beta-D-glucuronide, and calycosin sulfate. Calycosin and formononetin were proved absorbable by four methods; (6aR,11aR)-3-hydroxy-9,10-dimethoxypterocarpan and 7,2'-dihydroxy-3',4'-dimethoxyisoflavan were proved absorbable by three methods; formononetin-7-O-beta-D-glucoside and (6aR,11aR)-3-hydroxy-9,10-dimethoxypterocarpan-3-O-beta-D-glucoside were proved absorbable by two methods. The existence of calycosin-7-O-beta-D-glucuronide, formononetin-7-O-beta-D-glucuronide, (6aR,11aR)-3-hydroxy-9,10-dimethoxypterocarpan-3-O-beta-D-glucuronide, 7,2'-dihydroxy-3',4'-dimethoxyisoflavan-7-O-beta-D-glucuronide, and calycosin sulfate was proved by two or three methods. We found that besides isoflavones, pterocarpans and isoflavans also could be metabolized by the intestine during absorption, and the major metabolites were glucuronides. In conclusion, the present study demonstrated that the flavonoids in Astragali Radix decoction, including isoflavones, pterocarpans, and isoflavans, could be absorbed and metabolized by the intestine. These absorbable compounds, which were reported to have various bioactivities related to the curative effects of Astragali Radix decoction, could be regarded as an important component of the effective constituents of Astragali Radix decoction.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16507649     DOI: 10.1124/dmd.105.008300

Source DB:  PubMed          Journal:  Drug Metab Dispos        ISSN: 0090-9556            Impact factor:   3.922


  17 in total

1.  Identification of metabolites of Buyang Huanwu decoction in rat urine using liquid chromatography-quadrupole time-of-flight mass spectrometry.

Authors:  Xiao-Dong Wen; E-Hu Liu; Jie Yang; Chang-Yin Li; Wen Gao; Lian-Wen Qi; Chong-Zhi Wang; Chun-Su Yuan; Ping Li
Journal:  J Pharm Biomed Anal       Date:  2012-04-25       Impact factor: 3.935

2.  Occurrence of ochratoxin A in Astragalus propinquus root and its transfer to decoction.

Authors:  Jakub Toman; Vladimir Ostry; Yann Grosse; Tomas Roubal; Frantisek Malir
Journal:  Mycotoxin Res       Date:  2018-04-25       Impact factor: 3.833

3.  Chemical and genetic assessment of variability in commercial Radix Astragali (Astragalus spp.) by ion trap LC-MS and nuclear ribosomal DNA barcoding sequence analyses.

Authors:  Wei-Lie Xiao; Timothy J Motley; Uchenna J Unachukwu; Clara Bik San Lau; Bei Jiang; Feng Hong; Ping-Chung Leung; Qing-Feng Wang; Philip O Livingston; Barrie R Cassileth; Edward J Kennelly
Journal:  J Agric Food Chem       Date:  2011-02-15       Impact factor: 5.279

Review 4.  Astragalus mongholicus Bunge (Fabaceae): Bioactive Compounds and Potential Therapeutic Mechanisms Against Alzheimer's Disease.

Authors:  Qianyu Dong; Zhen Li; Qian Zhang; Yueyu Hu; Huazheng Liang; Lize Xiong
Journal:  Front Pharmacol       Date:  2022-06-28       Impact factor: 5.988

Review 5.  A systematic review of anticancer effects of radix astragali.

Authors:  Yeehong Jung; Uimin Jerng; Sookyung Lee
Journal:  Chin J Integr Med       Date:  2015-12-07       Impact factor: 1.978

6.  Screening and Identification of the Metabolites of Water Extracts of Raw and Honey-Processed Astragalus in Rat Urine Based on UHPLC/ESI-Q-TOF-MS and Multivariate Statistical Analysis.

Authors:  Jing Huang; Hongyuan Chen; Chanyi Li; Wuping Liu; Wenjie Ma; Wen Rui
Journal:  J Am Soc Mass Spectrom       Date:  2018-06-21       Impact factor: 3.109

7.  Study of the upregulation of the activity of cytochrome P450 3A isoforms by Astragalus injection and Astragalus granules in rats and in cells.

Authors:  Yongli Zhang; Ling Huang; Huichang Bi; Yuqiang Cui; Jingqing Li; Xiangsheng Wang; Xiaoling Qin; Jiangying Chen; Min Huang
Journal:  Eur J Drug Metab Pharmacokinet       Date:  2012-07-14       Impact factor: 2.441

8.  Explore the Mechanism of Astragalus mongholicus Bunge against Nonalcoholic Fatty Liver Disease Based on Network Pharmacology and Experimental Verification.

Authors:  Lili Fu; Zhongming Wu; Yanjun Chu; Wenbin Chen; Ling Gao; Shumin Mu; Jiajun Zhao
Journal:  Gastroenterol Res Pract       Date:  2022-04-05       Impact factor: 2.260

9.  Astragaloside IV Attenuates Glutamate-Induced Neurotoxicity in PC12 Cells through Raf-MEK-ERK Pathway.

Authors:  Rongcai Yue; Xia Li; Bingyang Chen; Jing Zhao; Weiwei He; Hu Yuan; Xing Yuan; Na Gao; Guozhen Wu; Huizi Jin; Lei Shan; Weidong Zhang
Journal:  PLoS One       Date:  2015-05-11       Impact factor: 3.240

10.  Hydrolysis of Glycosidic Flavonoids during the Preparation of Danggui Buxue Tang: An Outcome of Moderate Boiling of Chinese Herbal Mixture.

Authors:  Wendy Li Zhang; Jian-Ping Chen; Kelly Yin-Ching Lam; Janis Ya-Xian Zhan; Ping Yao; Tina Ting-Xia Dong; Karl Wah-Keung Tsim
Journal:  Evid Based Complement Alternat Med       Date:  2014-03-16       Impact factor: 2.629

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.